{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:25:06Z","timestamp":1790443506868,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA026476"],"award-info":[{"award-number":["DA026476"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13181-016-0558-4","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T14:08:52Z","timestamp":1464876532000},"page":"335-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose"],"prefix":"10.1007","volume":"12","author":[{"given":"Milana","family":"Zaurova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vlahov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex F.","family":"Manini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"issue":"144","key":"558_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","volume":"1","author":"MS Castaneto","year":"2014","unstructured":"Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;1(144):12\u201341.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"558_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","volume":"8","author":"J Guindon","year":"2009","unstructured":"Guindon J, Hohmann AG. The endocannabinoid system and pain. CNS Neurol Disord Drug Targets. 2009;8(6):403\u201321.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"558_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","volume":"197","author":"I Vardakou","year":"2010","unstructured":"Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197(3):157\u201362.","journal-title":"Toxicol Lett"},{"key":"558_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13181-011-0202-2","volume":"8","author":"CD Rosenbaum","year":"2012","unstructured":"Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow \u2026 back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012;8:15\u201332.","journal-title":"J Med Toxicol"},{"key":"558_CR5","doi-asserted-by":"crossref","unstructured":"Hermanns-Clausen M, Kithinji J, Spehl M, Angerer V, Franz F, Eyer F, et al. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project. Drug Test Anal. 2016; Jan 15.","DOI":"10.1002\/dta.1936"},{"issue":"3","key":"558_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","volume":"108","author":"M Hermanns-Clausen","year":"2013","unstructured":"Hermanns-Clausen M, Kneisel S, Szabo B, Auw\u00e4rter V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction. 2013;108(3):534\u201344.","journal-title":"Addiction"},{"key":"558_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jemermed.2010.10.014","volume":"40","author":"AB Schneir","year":"2011","unstructured":"Schneir AB, Cullen J, Ly BT. \u201cSpice\u201d girls: synthetic cannabinoid intoxication. J Emerg Med. 2011;40:296\u20139.","journal-title":"J Emerg Med"},{"key":"558_CR8","first-page":"e5","volume":"1320","author":"AC Young","year":"2012","unstructured":"Young AC, Schwarz E, Medina G, Obafemi A, Feng SY, Kane C, et al. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation. Am J Emerg Med. 2012;1320:e5\u20137.","journal-title":"Am J Emerg Med"},{"key":"558_CR9","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1360-0443.2010.03119.x","volume":"105","author":"S Every-Palmer","year":"2010","unstructured":"Every-Palmer S. Warning: legal synthetic cannabinoid-receptor agonists such as JWH 018 may precipitate psychosis in vulnerable individuals. Addiction. 2010;105:1859\u201360.","journal-title":"Addiction"},{"key":"558_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.schres.2009.12.001","volume":"118","author":"H M\u00fcller","year":"2010","unstructured":"M\u00fcller H, Sperling W, K\u00f6hrmann M, Huttner HB, Kornhuber J, Maler JM. The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes. Schizophr Res. 2010;118:309\u201310.","journal-title":"Schizophr Res"},{"key":"558_CR11","first-page":"464","volume":"106","author":"US Zimmermann","year":"2009","unstructured":"Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K. Withdrawal phenomena and dependence syndrome after the consumption of \u201cSpice Gold\u201d. Dtsch Artzebl Int. 2009;106:464\u20137.","journal-title":"Dtsch Artzebl Int"},{"issue":"10","key":"558_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1177\/0960327111421945","volume":"31","author":"MB Forrester","year":"2012","unstructured":"Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Hum Exp Toxicol. 2012;31(10):1006\u201311.","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"558_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","volume":"54","author":"RJ Tait","year":"2016","unstructured":"Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila). 2016;54(1):1\u201313.","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"558_CR14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1521-0391.2012.00240.x","volume":"21","author":"EW Gunderson","year":"2012","unstructured":"Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL. \u201cSpice\u201d and \u201cK2\u201d herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict. 2012;21(4):320\u20136.","journal-title":"Am J Addict"},{"issue":"7","key":"558_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1553-2712.2012.01397.x","volume":"19","author":"AF Manini","year":"2012","unstructured":"Manini AF, Nelson LS, Stimmel B, Vlahov D, Hoffman RS. Incidence of adverse cardiovascular events in adults following drug overdose. Acad Emerg Med. 2012;19(7):843\u20139.","journal-title":"Acad Emerg Med"},{"issue":"5","key":"558_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/acem.12658","volume":"22","author":"AF Manini","year":"2015","unstructured":"Manini AF, Hoffman RS, Stimmel B, Vlahov D. Clinical risk factors for in hospital adverse cardiovascular events after acute drug overdose. Acad Emerg Med. 2015;22(5):499\u2013507.","journal-title":"Acad Emerg Med"},{"issue":"11","key":"558_CR17","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","volume":"106","author":"A Winstock","year":"2011","unstructured":"Winstock A, Mitcheson L, Ramsey J, Marsden J. Mephedrone: use, subjective effects and health risks. Addiction. 2011;106(11):1991\u20136.","journal-title":"Addiction"},{"key":"558_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/cap.2012.0004","volume":"22","author":"O Oluwabusi","year":"2012","unstructured":"Oluwabusi O, Lobach L, Akhtar U, Youngman B, Ambrosini PJ. Synthetic cannabinoid induced psychosis: two adolescent cases. J Child Adolesc Psychopharmacol. 2012;22:393\u20135.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"558_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1521-0391.2012.00222.x","volume":"21","author":"S Peglow","year":"2012","unstructured":"Peglow S, Buchner III J, Briscoe G. Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient. Am J Addict. 2012;21:287\u20138.","journal-title":"Am J Addict"},{"issue":"4","key":"558_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s13181-014-0460-x","volume":"11","author":"AM Dines","year":"2015","unstructured":"Dines AM, Wood DM, Galicia M, Yates CM, Heyerdahl F, Hovda KE, et al. Euro-DEN research group, dargan PI. Presentations to the emergency department following cannabis use\u2014a multi-centre case series from ten european countries. J Med Toxicol. 2015;11(4):415\u201321.","journal-title":"J Med Toxicol"},{"key":"558_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ceca.2013.12.005","volume":"55","author":"LT Al Kury","year":"2014","unstructured":"Al Kury LT, Voitychuk OI, Ali RM, et al. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes. Cell Calcium. 2014;55:104\u201318.","journal-title":"Cell Calcium"},{"key":"558_CR22","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1111\/bph.12734","volume":"171","author":"LT Al Kury","year":"2014","unstructured":"Al Kury LT, Voitychuk OI, Yang KH, et al. Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. Br J Pharmacol. 2014;171:3485\u201398.","journal-title":"Br J Pharmacol"},{"key":"558_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ceca.2014.02.017","volume":"55","author":"LT Al Kury","year":"2014","unstructured":"Al Kury LT, Yang KH, Thayyullathil FT, et al. Effects of endogenous cannabinoid anandamide on cardiac Na(+)\/Ca(2)(+) exchanger. Cell Calcium. 2014;55:231\u20137.","journal-title":"Cell Calcium"},{"issue":"8","key":"558_CR24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3109\/15563650.2011.609822","volume":"49","author":"J Lapoint","year":"2011","unstructured":"Lapoint J, James LP, Moran CL, Nelson LS, Hoffman RS, Moran JH. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila). 2011;49(8):760\u20134.","journal-title":"Clin Toxicol (Phila)"},{"key":"558_CR25","doi-asserted-by":"publisher","first-page":"e1622","DOI":"10.1542\/peds.2010-3823","volume":"128","author":"A Mir","year":"2011","unstructured":"Mir A, Obafemi A, Young A, Kane C. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128:e1622\u20137.","journal-title":"Pediatrics"},{"issue":"2","key":"558_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jemermed.2015.10.009","volume":"50","author":"J Von Der Haar","year":"2016","unstructured":"Von Der Haar J, Talebi S, Ghobadi F, Singh S, Chirurgi R, Rajeswari P, et al. Synthetic cannabinoids and their effects on the cardiovascular system. J Emerg Med. 2016;50(2):258\u201362.","journal-title":"J Emerg Med"},{"key":"558_CR27","doi-asserted-by":"crossref","unstructured":"Ibrahim S, Al-Saffar F, Wannenburg T. A unique case of cardiac arrest following K2 abuse. Case Rep Cardiology. 2014;2014.","DOI":"10.1155\/2014\/120607"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-016-0558-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0558-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-016-0558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:58:34Z","timestamp":1589734714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-016-0558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1007\/s13181-016-0558-4","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]},"assertion":[{"value":"2 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Presented in abstract form at the XXXV International Congress, European Association of Poisons Centres and Clinical Toxicologists, St. Julian\u2019s, Malta, 2015.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Previous presentations"}}]}}